Retatrutide 20mg is being researched as an experimental, powerful weight-loss peptide, a "triple-agonist" that activates GLP-1, GIP, and glucagon receptors, leading to significant appetite suppression, slower digestion, and increased metabolism for substantial weight loss and improved blood sugar, though it's still in clinical trials and not FDA-approved

20 MG Lyophilized Powder in a Vial

Double tested at Janoshik labs (the gold standard of testing in Europe) and at Pure Analytical labs (ISO certified) in California to guarantee 99% purity with zero heavy metals and endotoxins.

Intended Use

This material is sold strictly for the purpose of laboratory research, including but not limited to:

• In vitro receptor binding assays.

• Peptide stability analysis.

• Chemical structure characterization.

• Non-clinical method development.

  
  

Restriction: This product is not a drug, food, or cosmetic. It has not been approved by the US Food and Drug Administration (FDA) for any clinical application. Any reference to potential therapeutic benefits is strictly prohibited.

Storage & Handling

• Lyophilized State: Store at -20°C (-4°F) or below. Keep vial specifically protected from light to maintain peptide integrity.

• Reconstitution: For best results, reconstitute using Bacteriostatic Water or Sterile Water for Injection (USP) strictly for solution preparation.

  
  

• After Reconstitution: The solution should be used immediately for research purposes. If storage is required, maintain at 4°C (39°F) and use within a standard research timeframe (typically 1-2 weeks). Avoid repeated freeze-thaw cycles as this may degrade the peptide chain.